Literature DB >> 8254813

Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction.

J H Kim1, M L Klyachkin, E Svendsen, M G Davies, P O Hagen, C C Carson.   

Abstract

Hypercholesterolemia and other vascular risk factors for atherosclerosis are commonly associated with impotence. To characterize cavernosal smooth muscle reactivity in hypercholesterolemia, we performed isometric tension studies (with norepinephrine, acetylcholine, papaverine and electrical field stimulation) on isolated strips of corpus cavernosum from rabbits fed a 1% cholesterol diet. To assess the impact of cholesterol reduction, a group of rabbits was fed a cholesterol diet for 4 weeks and was then returned to a normal diet for 4 weeks before testing. Potential structure-function relationships were delineated by ultrastructural evaluation with transmission electron microscopy (TEM). All forms of cavernosal relaxation, including papaverine relaxation, were impaired with hypercholesterolemia, and norepinephrine contraction was augmented. In addition, ultrastructural evidence of an early atherosclerotic process in the cavernosal sinusoids was detected. Importantly, reduction of elevated serum cholesterol normalized cavernosal relaxation, including that of papaverine, and decreased the sensitivity to norepinephrine, thereby suggesting that cavernosal smooth muscle dysfunction in hypercholesterolemia is reversible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254813     DOI: 10.1016/s0022-5347(17)34916-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Erectile dysfunction and atherosclerosis.

Authors:  Robert A Kloner; Mark Speakman
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

2.  Time-course changes of nLDL-induced erectile dysfunction.

Authors:  N Durmus; A Toylu; S Evcim; B C Soner; O Demir; E Kahraman; T Demir; B Irer; S Gidener; N Atabey; A Esen
Journal:  Int J Impot Res       Date:  2017-03-16       Impact factor: 2.896

3.  Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase.

Authors:  Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Travis D Strong; Sena F Sezen; Justin M Johnson; Arthur L Burnett
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

4.  Is apolipoprotein-(a) an important indicator of vasculogenic erectile dysfunction?

Authors:  O Atahan; O Kayigil; N Hizel; A Metin
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice.

Authors:  Victor E Esenabhalu; Mirza Cerimagic; Roland Malli; Karin Osibow; Sanja Levak-Frank; Maud Frieden; Wolfgang Sattler; Gerhard M Kostner; Rudolf Zechner; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction.

Authors:  M Tolga Dogru; M Murad Basar
Journal:  Int Urol Nephrol       Date:  2009-10-29       Impact factor: 2.370

8.  Low-fat diet and exercise preserve eNOS regulation and endothelial function in the penis of early atherosclerotic pigs: a molecular analysis.

Authors:  Biljana Musicki; Tongyun Liu; Travis Strong; Liming Jin; M Harold Laughlin; James R Turk; Arthur L Burnett
Journal:  J Sex Med       Date:  2008-01-10       Impact factor: 3.802

9.  Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment.

Authors:  Valter Javaroni; Mario Fritsch Neves
Journal:  Int J Hypertens       Date:  2012-05-09       Impact factor: 2.420

10.  Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.

Authors:  Rodrigo Araujo Fraga-Silva; Fabiana Pereira Costa-Fraga; Fabrizio Montecucco; Younouss Faye; Silvia Quintao Savergnini; Sébastien Lenglet; François Mach; Sabine Steffens; Nikolaos Stergiopulos; Robson Augusto Souza dos Santos; Rafaela Fernandes da Silva
Journal:  Clin Dev Immunol       Date:  2013-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.